Abciximab
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
ardeparin
Low molecular weight heparin · Anticoagulant
Low molecular weight heparinAnticoagulant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- AbciximabSevereDatabaseDDInter
- AcalabrutinibSevereDatabaseDDInter
- AlteplaseSevereDatabaseDDInter
- AnagrelideSevereDatabaseDDInter
Mechanism
Not yet extracted
Indications
Prophylaxis of deep vein thrombosisProphylaxis of pulmonary embolism (in high-risk patients undergoing surgery; stroke or other immobilized patients)Treatment of established deep vein thrombosisUnstable anginaMyocardial infarctionMaintain patency of cannulae and shunts in dialysis patients
Dosing
- Adult
- 2500-5000 IU OD
Drug interactions
Acalabrutinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Alteplase
Severe
Database
Clinical effect not specified
Source: DDInter
Anagrelide
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Antithrombin Alfa
Severe
Database
Clinical effect not specified
Source: DDInter
Antithrombin Iii Human
Severe
Database
Clinical effect not specified
Source: DDInter
Apixaban
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Argatroban
Severe
Database
Clinical effect not specified
Source: DDInter
Aspirin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Avapritinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Betrixaban
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Bivalirudin
Severe
Database
Clinical effect not specified
Source: DDInter
Related guidelines
ST-elevation myocardial infarction
CSI · Cardiology · 2020
Venous thromboembolism prophylaxis
ASH · Haematology · 2018
Acute coronary syndrome
CSI · Cardiology · 2022
Preoperative cardiac evaluation for non-cardiac surgery
AHA · Cardiology · 2025
Dialysis — initiation and maintenance
ISN_INDIA · Nephrology · 2023
Other Low molecular weight heparin drugs
Ask House about ardeparin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team